These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22697111)

  • 1. Mast cells positive for cluster of differentiation 117 protein: are they players or conductor in the orchestra of cholesteatoma?
    Calli AO; Sari A; Cakalagaoglu F; Altinboga AA; Calli C; Oncel S
    J Laryngol Otol; 2012 Aug; 126(8):775-9. PubMed ID: 22697111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
    Durko M; Kaczmarczyk D
    Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mastocytes in chronic inflammation of middle ear mucosa].
    Sanković S; Dergenc R; Bojić P
    Srp Arh Celok Lek; 1999; 127(1-2):35-8. PubMed ID: 10377839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on distribution of α1-antitrypsin, lysozyme, lactoferrin, and mast cell enzymes in diseased middle ear mucosa.
    Kim JS; Yoon YJ; Lee EJ
    Acta Otolaryngol; 2014 Aug; 134(8):791-5. PubMed ID: 24931056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential expression of toll-like receptors in chronic suppurative otitis media and cholesteatoma].
    Si Y; Zhang ZG; Huang CY; He JF; Feng LQ; Chen YB; Chen T; Huang X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):388-93. PubMed ID: 22883581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma].
    Welkoborsky HJ
    Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells in human middle ear mucosa in health and in disease.
    Berger G; Hawke M; Ekem JK; Johnson A
    J Otolaryngol; 1984 Dec; 13(6):370-4. PubMed ID: 6085806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
    Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins in human cholesteatoma and granulation tissue.
    Jung TT; Juhn SK
    Am J Otol; 1988 May; 9(3):197-200. PubMed ID: 3177602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of interleukin-1 in middle ear cholesteatoma.
    Shiwa M; Kojima H; Kamide Y; Moriyama H
    Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteatoma in children: histopathologic findings in middle ear ossicles.
    Quaranta A; Bartoli R; Lozupone E; Resta L; Iurato S
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):296-8. PubMed ID: 8587786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells in chronic inflammation of the middle ear mucosa.
    Sankovic S; Dergenc R; Bojic P
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):15-8. PubMed ID: 16080642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen in chronic otitis media: an immunohistochemical study of the middle ear mucosa.
    Sankovic S; Sofronic L
    Acta Otorhinolaryngol Belg; 2002; 56(1):61-4. PubMed ID: 11894632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone resorption in chronic otitis media. The role of mast cells.
    Berger G; Hawke M; Ekem JK
    Acta Otolaryngol; 1985; 100(1-2):72-80. PubMed ID: 2411102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral ear in chronic otitis media: a histologic study.
    Rosito LP; da Costa SS; Schachern PA; Dornelles C; Cureoglu S; Paparella MM
    Laryngoscope; 2007 Oct; 117(10):1809-14. PubMed ID: 17906499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The theory of the trigger, the bridge and the transmigration in the pathogenesis of acquired cholesteatoma.
    Goycoolea MV; Hueb MM; Muchow D; Paparella MM
    Acta Otolaryngol; 1999 Mar; 119(2):244-8. PubMed ID: 10320085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.